Stuart Adams says the legislature has already authorized an audit, which is expected in the fall.
After a recent Salt Lake Tribune report that the Securities and Exchange Commission investigated how Salt Lake City Co-Diagnostics COVID-19 tests were used during Silicon Slopes’ TestUtah initiative, the Senate Speaker Stuart Adams, R-Layton, information as “relating to”.
The Tribune’s investigation found that a Silicon Slopes board member used his connections with Senator Mitt Romney’s office to seek help with FDA approval for the tests. Adams said in an email that the legislature authorized an audit of the Utah Department of Health by the legislative auditor general in October, and that he expects them to present their findings this fall when the audit will be completed.
According to legislative site, the legislative audit subcommittee decided to “prioritize an efficiency and effectiveness audit of the Utah Department of Health” on October 13, as well as “an audit of data and criteria that government entities use to make critical decisions related to COVID-19 ”. The motion was carried with a 5-0 vote.
“Last year we were in the middle of a pandemic and we were trying to save lives and livelihoods,” Adams wrote in an email. “We were informed that there was a charitable effort from these companies to help during this crisis. It is baffling to learn of the financial gains and the SEC investigation. We need more information to fully understand what happened.
Last year, state officials, including Adams, wanted to make the antimalarial drug hydroxychloroquine available to the Utahns as an off-label treatment for COVID-19.
Meds In Motion Pharmacy CEO and pharmacist Dan Richards, who admitted to mislabeling one of his imported drugs as a herbal supplement, contacted state officials in March to alert them that he had purchased approximately 1,760 pounds of crude hydroxychloroquine. His efforts to stock the drug have drawn support from officials like Adams, who was with the pharmacist at a March press conference at the State Capitol to promote the drugs.
Utah officials contacted by Richards insist they did not know Richards was mislabeling the drug until he was charged.